Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may enhance the drug's ability to regulate blood sugar, potentially offering more significant outcomes for individuals with type 2 diabetes. Further investigation is underway to fully evalua